<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01211925</url>
  </required_header>
  <id_info>
    <org_study_id>440/III-3</org_study_id>
    <nct_id>NCT01211925</nct_id>
  </id_info>
  <brief_title>Distal Venous Arterialisation of Ischemic Limb</brief_title>
  <official_title>Distal Venous Arterialisation in the Treatment of Critical Ischemia of Lower Limb</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Centre of Serbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Centre of Serbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Distal venous arterialisation (DVA) improve outcome in patients with nonreconstructible
      peripheral arterial occlusive disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study was to estimate validity of distal venous arterialisation (DVA) as a
      limb salvage procedure. This prospective randomized study reported early results of 30
      unreconstructible patients with critical limb ischemia (CLI) treated during 2009 year at
      Clinic for vascular surgery, Clinical Center of Serbia in Belgrade. Patients were divided in
      two groups, 10 treated with DVA and 20 conservatively (CT) using antiplatelet drugs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>limb salvage</measure>
    <time_frame>1 year</time_frame>
    <description>The investigators will estimate clinical improvement in patients with critical limb ischemia underwent of distal venous arterialisation. Comparative group consist patients treated with antiplatelet drugs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lactate level in the blood of deep venous system</measure>
    <time_frame>1 year</time_frame>
    <description>The investigators measure metabolic changes in the patients after distal venous arterialisation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>critical ischemia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Best medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>distal venous arterialisation</intervention_name>
    <description>The investigators perform reverse revascularisation of the ischemic limb with arterial blood supply from patent in flow artery to the superficial dorsal venous arch.</description>
    <arm_group_label>critical ischemia</arm_group_label>
    <other_name>Venous arterialisation, arteriovenous reversal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>100 mg per day continuous</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Absence of any possibility for direct revascularisation due to extensive occlusive
             disease of crural and pedal arteries

          -  Sufficient deep venous system and usable great saphenous vein as a graft for in situ
             bypass surgery according duplex scanning

          -  localized infective of necrotic process up to the metatarsal level

          -  Satisfactory general patient condition

        Exclusion Criteria:

          -  advanced lower limb ischemia

          -  venous insufficiency of lower limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Predrag Vl Djoric, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Center of Serbia in Belgrade, Clinic for Vascular and Endovascular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2010</study_first_submitted>
  <study_first_submitted_qc>September 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>September 29, 2010</last_update_submitted>
  <last_update_submitted_qc>September 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Clinic for Vascular and Endovascular Surgery</name_title>
    <organization>Clinical Center of Serbia, Belgrade</organization>
  </responsible_party>
  <keyword>unreconstructable peripheral arterial disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

